Literature DB >> 15292914

Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.

N J Caplen1.   

Abstract

The control and maintenance of gene expression is critical for cell development and differentiation. Over the last 2 years, our understanding of the role of RNA as a regulator of gene expression has significantly increased. Small RNA molecules are key elements of a machinery that trigger chromosomal modifications, post-transcriptional gene silencing and protein translational blockade depending on the source, the RNA and the nature of the interaction with the target nucleic acid. Currently, the best characterized of this group of RNA-mediated gene regulation pathways is the post-transcriptional gene silencing mechanism known as RNA interference. RNAi is triggered by double-stranded RNA (dsRNA), which induces the formation of a ribonucleoprotein complex that mediates sequence-specific cleavage of the transcript cognate with the input dsRNA. RNAi has been adapted as a functional genomics tool and it has potential as a therapeutic approach. This review will summarize our current understanding of the RNAi mechanism and the various applications of RNAi-based technologies.

Mesh:

Substances:

Year:  2004        PMID: 15292914     DOI: 10.1038/sj.gt.3302324

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  29 in total

Review 1.  Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.

Authors:  David A Dean
Journal:  Am J Physiol Cell Physiol       Date:  2005-08       Impact factor: 4.249

Review 2.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

3.  Construction and identification of Fas-targeting siRNA-expressing plasmid.

Authors:  Su-hu Liu; Wang-gang Zhang; Mei Zhang; Qing Zhu; Wei Tian
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

4.  Alternative for anti-TNF antibodies for arthritis treatment.

Authors:  Joseph Paquet; Christel Henrionnet; Astrid Pinzano; Jean-Baptiste Vincourt; Pierre Gillet; Patrick Netter; Isabelle Chary-Valckenaere; Damien Loeuille; Jacques Pourel; Laurent Grossin
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

Review 5.  RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy.

Authors:  Fang Cheng; Song He
Journal:  Mol Biol Rep       Date:  2009-09-12       Impact factor: 2.316

6.  Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.

Authors:  Shurong Huang; Lishan Chen; Nataliya Libina; Joel Janes; George M Martin; Judith Campisi; Junko Oshima
Journal:  Hum Genet       Date:  2005-10-06       Impact factor: 4.132

7.  Towards understanding the epigenetics of transcription by chromatin structure and the nuclear matrix.

Authors:  Rui Pires Martins; Stephen A Krawetz
Journal:  Gene Ther Mol Biol       Date:  2005

8.  Effects of PI3-k/Akt short hairpin RNA on proliferation, fibronectin production and synthesis of thrombospondin-1 and transforming growth factor-beta1 in glomerular mesangial cells induced by sublytic C5b-9 complexes.

Authors:  L Gao; Y Zhang; W Qiu; W Xu; X Feng; J Ren; X Jiang; H Wang; D Zhao; Y Wang
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

9.  A human full-skin culture system for interventional studies.

Authors:  Lars Steinstraesser; Andrea Rittig; Kai Gevers; Michael Sorkin; Tobias Hirsch; Marco Kesting; Michael Sand; Sammy Al-Benna; Stefan Langer; Hans-Ulrich Steinau; Frank Jacobsen
Journal:  Eplasty       Date:  2009-01-09

10.  Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.

Authors:  Yusuke Ohnishi; Katsushi Tokunaga; Kiyotoshi Kaneko; Hirohiko Hohjoh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.